Addex Therapeutics Ltd. Income Statement

Income Statement Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -2.19B0.00B0.00B0.00B
Cost of Revenue 0.00B0.00B0.00B
Gross Profit 0.00B0.00B0.00B
Operating items
Depreciation & Amortization - Total -350.65B0.00B0.00B0.00B
Research & Development 0.01B0.00B0.00B
Selling, General & Administrative 0.00B0.00B0.00B
Other Operating Expenses -0.00B-0.00B-0.00B
Operating Expenses -350.65B0.01B0.00B0.00B
Operating Income -0.01B-0.00B-0.00B
EBIT -0.01B-0.00B-0.00B
Non-operating items
Interest & Investment Income 0.00B0.00B0.00B
Other Non Operating Income -0.00B-0.00B0.00B
Non Operating Income -0.00B-0.00B0.00B
Net income details
EBT -0.01B-0.00B-0.01B
Profit After Tax -0.02B-0.01B0.01B
Equity Income -0.00B
Income from Continuing Operations -0.01B-0.00B-0.01B
Consolidated Net Income -0.01B-0.01B0.01B
Income towards Parent Company -0.01B-0.01B0.01B
Net Income towards Common Stockholders -0.02B-0.01B0.01B
Additional items
EPS (Basic) -0.48-0.160.08
EPS (Weighted Average and Diluted) -0.48-0.160.08
Shares Outstanding (Weighted Average) 0.04B0.07B0.10B
EBITDA -0.01B-0.00B-0.00B
Interest Expenses 0.00B0.00B0.00B